The US sepsis biomarkers market is expected to grow due to increasing cases of severe infections, rising demand for early diagnosis solutions, and advancements in critical care diagnostics. The growing focus on improving patient outcomes and adopting advanced biomarker-based testing methods is supporting market growth across hospitals and healthcare facilities.
The Sepsis Biomarkers Market...
SPARK Website
عربي